Women's Health
What Causes High Testosterone in Women?
Elevated testosterone is one of the most commonly missed hormonal findings in women's lab work — yet it drives some of the most visible and distressing symptoms. Understanding what's pushing androgens high is the first step to a targeted, evidence-based response.

What Causes High Testosterone in Women?
The most common cause is polycystic ovary syndrome (PCOS), which accounts for roughly 70–80% of cases of elevated androgens in women. Insulin resistance, adrenal overactivity, and certain medications are the next most frequent culprits. The caveat: "high" testosterone in women is defined by the lab range used, and many women sit above reference range without any obvious symptoms — context and trends matter more than a single number.
---
Understanding Testosterone in Women: What's Normal?
Testosterone is not exclusively a male hormone. Women produce it in the ovaries and adrenal glands, and at physiological levels it supports libido, bone density, mood, and lean muscle maintenance. Normal total testosterone in adult women generally falls between 15–70 ng/dL, though laboratory reference ranges vary slightly by assay and life stage.
When total testosterone rises above roughly 70–80 ng/dL — or when free testosterone climbs disproportionately — signs of androgen excess begin to emerge. For a deeper look at how testosterone ranges shift across the lifespan, see our breakdown of optimal testosterone levels by age for men and women.
The clinical term for persistently elevated androgens in women is hyperandrogenism. It is not a diagnosis in itself but a biomarker pattern that points toward an underlying cause.
---
The Leading Causes of High Testosterone in Women
1. Polycystic Ovary Syndrome (PCOS)
PCOS is the most prevalent endocrine disorder in reproductive-age women, affecting an estimated 8–13% globally (Teede et al., Human Reproduction Update 2018; PMID: 29538576). The Rotterdam diagnostic criteria require at least two of three features: irregular ovulation, clinical or biochemical hyperandrogenism, and polycystic ovarian morphology on ultrasound.
The testosterone elevation in PCOS is driven by several interlocking mechanisms:
- Insulin resistance stimulates the ovarian theca cells to overproduce androgens.
- Elevated LH (luteinizing hormone) disproportionate to FSH amplifies androgen synthesis in the same cells.
- Reduced sex hormone–binding globulin (SHBG) — commonly caused by high insulin — leaves more testosterone unbound and biologically active.
This is why fasting insulin and SHBG are nearly as important as testosterone itself when evaluating androgen status. You can learn more about insulin-related patterns in what causes high fasting insulin in women.
2. Adrenal Hyperandrogenism
The adrenal glands produce their own androgens — primarily DHEA-S and androstenedione — which convert peripherally to testosterone. Adrenal causes of elevated testosterone include:
- Congenital adrenal hyperplasia (CAH): Even non-classic (late-onset) CAH, caused by 21-hydroxylase deficiency, can present in adult women with androgen excess that is easily confused with PCOS.
- Adrenal tumors: Rare but must be ruled out when testosterone is markedly elevated (>150–200 ng/dL) with rapid onset of symptoms.
- Chronic stress and HPA-axis dysregulation: Sustained cortisol demand drives DHEA-S upward, contributing to the androgen pool over time.
3. Insulin Resistance and Metabolic Syndrome
Insulin directly stimulates ovarian androgen production. A landmark mechanistic study showed that reducing hyperinsulinemia — via diet or metformin — consistently lowers testosterone and raises SHBG in women with PCOS (Nestler et al., New England Journal of Medicine 1996; PMID: 8992085). Even women without a PCOS diagnosis can show subclinical hyperandrogenism if insulin is chronically elevated.
This connection makes fasting glucose, fasting insulin, and HOMA-IR some of the most clinically informative companion tests to a testosterone panel.
4. Thyroid Dysfunction
Hypothyroidism reduces SHBG synthesis in the liver, which increases the fraction of free testosterone even without changing total testosterone production. Conversely, some women with thyroid autoimmunity show downstream effects on the HPO (hypothalamic-pituitary-ovarian) axis that alter androgen metabolism. Elevated TSH often coexists with androgen excess findings — a relationship explored in more detail in what causes high TSH in women.
5. Medications and Exogenous Hormones
Several medications raise androgens or displace testosterone from SHBG:
- Anabolic steroids and testosterone replacement therapy (direct addition to the androgen pool)
- Danazol (used for endometriosis)
- Some progestins with androgenic activity (e.g., levonorgestrel, norethindrone)
- Valproic acid (anticonvulsant linked to PCOS-like features)
Always review medication history before attributing elevated testosterone solely to an endogenous cause.
6. Rare Endocrine Tumors
Androgen-secreting tumors of the ovary (e.g., Sertoli-Leydig cell tumors) or adrenal gland are uncommon but should be suspected when:
- Total testosterone exceeds 150–200 ng/dL
- Onset is rapid (weeks to months)
- Virilization symptoms (clitoromegaly, voice deepening) are present
Imaging and specialist referral are essential in this scenario.
---
Symptoms of High Total Testosterone in Women
The clinical presentation of hyperandrogenism varies with the magnitude of elevation and individual sensitivity at the androgen receptor level. Common symptoms include:
| Symptom | Mechanism |
|---|---|
| Hirsutism (coarse facial/body hair) | 5α-reductase converts testosterone → DHT at the hair follicle |
| Acne (cystic, hormonal pattern) | Sebaceous gland overstimulation by DHT |
| Scalp hair thinning (androgenic alopecia) | DHT-mediated follicle miniaturization |
| Irregular or absent periods | Excess androgens disrupt LH/FSH pulsatility |
| Clitoral enlargement (severe cases) | Direct androgenic effect |
| Mood changes, irritability | Androgen receptor activity in the CNS |
| Reduced breast tissue | Counter-estrogenic effect of high androgens |
| Deepened voice (severe, prolonged) | Laryngeal cartilage changes |
It is worth noting that symptom severity does not always correlate directly with the degree of testosterone elevation. Some women with modestly elevated levels have significant hirsutism due to higher 5α-reductase activity in hair follicles, while others with similar lab values are nearly asymptomatic. For a broader picture of androgen-related findings, testosterone in women: when to test and the signs of androgen imbalance walks through the testing sequence in detail.
---
The Diagnostic Workup: Beyond a Single Testosterone Number
A comprehensive evaluation of high testosterone in women typically includes:
- Total and free testosterone (trough levels, ideally morning draw)
- SHBG — low SHBG magnifies the effect of even borderline-elevated total testosterone
- DHEA-S — elevated DHEA-S points toward adrenal origin
- LH and FSH ratio — LH:FSH > 2 is a classic PCOS signal
- Fasting insulin and glucose (HOMA-IR)
- Prolactin — hyperprolactinemia can suppress SHBG and alter androgen metabolism
- 17-hydroxyprogesterone (17-OHP) — screens for non-classic CAH
- TSH and free T3/T4 — thyroid status affects SHBG and androgen clearance
Abnormal ferritin can also complicate androgen metabolism; what causes high ferritin in women outlines the inflammatory mechanisms that sometimes run alongside PCOS.
---
Lifestyle and Nutritional Approaches That Affect Androgen Levels
Before considering pharmaceutical intervention, several evidence-based lifestyle strategies have demonstrated meaningful reductions in androgen markers:
Diet and Insulin Management
Low-glycemic and Mediterranean-style diets reduce fasting insulin and — through SHBG recovery — effectively lower free testosterone. A 2013 randomized controlled trial in women with PCOS found that a low-glycemic diet improved menstrual regularity and reduced free androgen index compared to a conventional healthy diet (Marsh et al., American Journal of Clinical Nutrition 2010; PMID: 20881074).
Resistance Training
Moderate resistance exercise improves insulin sensitivity without acutely raising testosterone to pathological levels in women — a concern that is largely unfounded at population doses. Improved HOMA-IR from structured exercise correlates with reduced androgen excess over 12–24 weeks in PCOS trials.
Inositol
Myo-inositol and D-chiro-inositol are among the most studied nutritional interventions for PCOS-related hyperandrogenism. Meta-analyses show combined inositol supplementation reduces fasting insulin, total testosterone, and LH:FSH ratio (Pkhaladze et al., Gynecological Endocrinology 2020; PMID: 31928095).
Zinc
Zinc inhibits 5α-reductase activity, which reduces conversion of testosterone to the more potent DHT. In one placebo-controlled trial in hyperandrogenic women, zinc supplementation reduced hirsutism scores and androgen markers over 8 weeks (Jamilian et al., Journal of Trace Elements in Medicine and Biology 2016; PMID: 27049134).
---
What This Means for Your Formula
Addressing elevated testosterone in women requires matching the intervention to the root cause — not simply adding an "anti-androgen" supplement. Ones analyzes blood work including testosterone, SHBG, fasting insulin, and thyroid markers, then builds a targeted capsule formula around the specific pattern identified.
For women whose hyperandrogenism is driven by insulin resistance, the formula may include Berberine (500–1500 mg/day), which activates AMPK — the same energy-sensing pathway as metformin — and has been shown to reduce testosterone and improve HOMA-IR in PCOS patients in a head-to-head trial (Li et al., European Journal of Endocrinology 2015; PMID: 25824066). Ones sources berberine at clinically active doses aligned with this evidence.
For the inflammatory and adrenal-driven pattern, Zinc at 25–45 mg elemental per day supports 5α-reductase inhibition and helps moderate the DHT amplification of the androgen signal. And for women where chronic stress and HPA-axis overactivation are contributing to DHEA-S elevation, Ones' Adrenal Support blend addresses the cortisol-androgen interplay at the level of adrenal output — without suppressing the axis.
Because testosterone excess rarely operates in isolation, Ones' AI practitioner evaluates the full panel — including companion markers like CRP, ferritin, and thyroid — before finalizing the formula. That systems-level view is what separates a personalized capsule plan from a generic women's hormonal supplement.
---
Key Takeaways
- PCOS accounts for 70–80% of hyperandrogenism in women — but adrenal, thyroid, and metabolic causes must be systematically ruled out before landing on that diagnosis.
- Insulin resistance is a central driver, elevating ovarian testosterone production and suppressing SHBG simultaneously — addressing insulin is often the highest-leverage intervention.
- Free testosterone and SHBG matter as much as total testosterone — a woman with low-normal total testosterone and very low SHBG can be functionally hyperandrogenic.
- Symptoms range from acne and hirsutism to cycle disruption — severity depends on both the degree of elevation and individual receptor sensitivity, not lab numbers alone.
- Zinc, inositol, and berberine each have randomized trial data supporting their use in androgen-excess patterns driven by insulin resistance or 5α-reductase overactivity.
- Always investigate rapidly rising or markedly elevated testosterone (>150 ng/dL) with imaging to rule out rare androgen-secreting tumors before attributing findings to PCOS.
---
This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting or adjusting any supplement or treatment protocol.